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Use of SpiderFX Embolic Protection Device vs. Distal Embolic Event: Hospital
Length of Stay, Operating Room Time, Costs and Mortality
Eric J. Dippel1, Niraj Parikh2, Katrine L. Wallace2
1Midwest Cardiovascular Research Foundation, Davenport, IA, 2Covidien, Mansﬁeld,
MA
Background: Distal embolization (DE) is a potential complication of percutaneous
atherectomy and other endovascular procedures that can lead to poor outcomes for the
patient and escalated costs for hospitals. Embolic protection (EP) devices have been
shown in several studies to have a low failure rate, and thus reduce the incidence of
these events. This study compared inpatient hospital costs and resource utilization in
two non-coronary (presumed lower extremity) atherectomy patient populations: (1)
a DE event group, and (2) a SpiderFX Embolic Protection Device (Covidien,
Plymouth, MN) group.
Methods: All inpatient discharges for atherectomy of non-coronary vessels (ICD-9-
CM procedure code 39.50) were selected from a comprehensive hospital admissions
database (Premier Perspective CY2006-Q3 of CY2012). Of these, DE patients were
identiﬁed using ICD-9-CM diagnosis codes (444.xx, 434.0, and 434.1). Patients using
a SpiderFX Device were identiﬁed using a product keyword search. Discharges in
both the groups were matched 1:1 using propensity score methodology, adjusting for
age, gender, race, region and severity. Hospital length of stay, operating room (OR)
time, costs and inpatient mortality were compared between the groups.
Results: A total of 624 matched pairs were identiﬁed for the ﬁnal analysis. Hospital
stay averaged 1.4 days longer in the DE patients (p<0.0001) compared to the Spi-
derFX Device patients. OR time was 38 minutes longer for DE patients (p¼0.02).
Total costs were higher but not statistically signiﬁcant for the DE group ($21,709 vs.
$19,948, p¼0.10). Room and board, pharmacy, laboratory and diagnostic costs were
all signiﬁcantly higher for DE than for the SpiderFX Device (p<0.05). The inpatient
mortality rate was higher in the DE group but not statistically signiﬁcant (1.8% vs.
0.80%, p¼0.13).
Conclusions: The use of the SpiderFX Device is strongly associated with shorter
hospital stays and shorter OR times. Cumulatively, these ﬁndings demonstrate
embolic protection devices such as the SpiderFX Device may signiﬁcantly reduce
consumption of hospital resources.
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Impact of below the knee lesions to outcome in patients implanted stent for
superﬁcial femoral artery chronic total occlusion lesion.
Maoto Habara1, Yoshihisa Kinoshita1, Tetsuo Matsubara2, Kenya Nasu2,
Takahiko Suzuki1, Mitsuyasu Terashima1
1Toyohashi Heart Center, Toyohashi, Japan, 2Toyohashi Heart Center, Toyohashi,
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Background: The purpose of this study was to identify the relationship between
below the knee (BTK) lesions and outcomes after endovascular treatment (EVT) of
chronic total occlusion (CTO) lesion in the superﬁcial femoral artery (SFA).
Methods: From June 2001 to November 20011, 209 atherosclerosis obliterans
patients underwent endovascular therapy for only SFA CTO lesions with self-
expanding stents. After the EVT, ﬁnal angiography was performed to evaluate the
blow the knee lesions and number of vessels (0 - 3) in BTK with CTO lesions were
counted. Within them, 120 limbs in 120 patients were performed 9 months follow up
angiography.
Results: In total, 31 patients (25.8%) were showed in-stent occlusion and 63 patients
(52.5%) were revealed in-stent restenosis including stent occlusion. The patients with
stent occlusion were more frequently observed BTK lesions at stent implantation
compared to the patients without stent occlusion (83.9% vs 58.4%; p¼0.02). Simi-
larly, the patients with in-stent restenosis were aloso more frequently observed BTK
lesions (76.2% vs 45.6%; p<0.001). The re-occlusion rate was signiﬁcantly higher in
the patients with 1 or 3 BTK lesions than patients without BTK CTO lesion. In
addition, the restenosis rate was also higher in the patients with 1 or 2 BTK CTO
lesions than patients without BTK lesions.
Conclusions: Re-occlusion and restenosis rate of the patients treated SFA CTO
lesions may be associated to the distal run-off vessel disease.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-533
Drug-Eluting Balloon for treatment of superﬁcial femoral artery in-stent
restenosis. Two years results from an Italian registry.
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Background: The patency rate of treated SFA has been improved through use of the
self-expanding nitinol stents. As the population with SFA stenting continues to
increase, occurrence of in-stent restenosis (ISR) has become a thoughtful problem.
The use of DEB has showed promising results in reducing restenosis recurrence in
coronary stents. Accordingly, the purpose of this prospective registry was to evaluate
the safety and efﬁcacy, at 2 years, of the use of drug-eluting balloons (DEB) for the
treatment of superﬁcial femoral artery (SFA) in-stent restenosis (ISR).
Methods: From December 2009 to December 2010, 39 consecutive patients under-
went PTA of SFA-ISR in our institution. All patients underwent conventional SFA
PTA and ﬁnal post-dilation with paclitaxel-eluting balloons (IN.PACT, Medtronic,
Minneapolis, Minnesota). Clinical follow-up and duplex ultrasonography scan were
performed at 30 days, and at 3, 6, 12, 18 and 24 months post-procedure. Repeat
angiography was performed when proximal ﬂow velocity ratio (PVR) was between
2.4 and 5.0 (intermediate restenosis) and when the patient had clinical symptoms or
> 5.0 (severe restenosis) regardless clinical symptoms and in case of stent occlusion.
Results: Technical and procedural success was achieved in every patient. No in-
hospital major adverse cardiac and cerebrovascular events occurred. At 2 years, 2
patient died (1 due to heart failure and 1 due to myocardial infarction). Primary
endpoint, primary patency rate at 24 months, was obtained in 70.3% (26 patients). The
presence of an occlusive restenosis at the time of treatment was not associated with an
increased restenosis rate, when compared with non-occlusive restenosis, at 2 years.
Conclusions: The data suggest that adjunctive use of DEB for the treatment of SFA-
ISR represents a potentially safe and effective therapeutic strategy. These data should
be considered hypothesis-generating to design a randomized trial.
TCT-534
To cover or not to cover deep femoral arteries in stenting for bifurcation lesions
of superﬁcial femoral artery
Sung-Jin Hong1, Young-Guk Ko1, Jung-Sun Kim1, Myeong-Ki Hong1,
Yang soo Jang1, Donghoon Choi1
1Severance Cardiovascular Hospital, Yonsei University, Seoul, Korea, Republic of
Background: We evaluated the clinical impact of different stenting strategies, to
cover or not to cover deep femoral arteries (DFA) in proximal superﬁcial femoral
artery (SFA) stenting, on the patency of SFA and to identify subgroups of patients for
whom these different stenting strategies have stronger association with better patency
for SFA bifurcation.
Methods: Between 2005 and 2012, 149 limbs stented at proximal SFA were retro-
spectively enrolled and classiﬁed into 2 groups according to stenting strategies; 85
limbs (57%) with coverage of DFA, group 1 and 64 limbs (43%) stented without
coverage of DFA, group 2. The fate of DFA and primary patency of SFA were
compared.
Results: Flow-limitation of DFA after stenting were observed in 14 limbs (9%) for
overall, 10 limbs (12%) in group 1 and 4 limbs (6%) in group 2 (p¼0.25). 85 limbs
had follow-up CT angiography within 2 yrs and no stenosis of DFA were observed in
both groups. Primary patency of SFA at 1 yr and 3 yr for overall limbs was 75% and
56%. Primary patency was not signiﬁcantly different between 2 groups (p¼0.22),
although there was a trend of higher patency in group 1 up to 2 yrs. In subgroup
analysis, there was a signiﬁcant interaction between stenting strategy and approach
method (p¼0.03). Group 1 had signiﬁcantly higher patency in subgroup of intra-
luminal approach (p¼0.01), whereas there were no difference in patency between 2
groups in subgroup of subintimal approach (p¼0.84).acts/POSTER/Endovascular Intervention B161
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SConclusions: The incidence of jailed DFA was acceptable and coverage of DFA in
stenting the proximal SFA had higher primary patency, especially with intraluminal
approach.
TCT-535
Correlation of Toe-Brachial Indices with Infragenicular Arterial Patency in
Critical Limb Ischemia
Jessen Jacob1, Matthew C. Bunte1, Michael Maier1, Mehdi Shishehbor1
1Cleveland Clinic, Cleveland, OH
Background: Current ACC/AHA guidelines recommend toe-brachial indices (TBI)
for diagnosis of peripheral arterial disease when ankle-brachial indices are unreliable
due to non-compressible vessels. We sought to investigate how well TBI correlates
with Rutherford classiﬁcation and infragenicular arterial patency in critical limb
ischemia (CLI).
Methods: Between July 2011 and February 2013, among patients who presented to
the Cleveland Clinic Lower Extremity Wound Clinic with Rutherford Category 4-6
symptoms, 41 patients had TBI and lower extremity angiography performed. The
correlation between TBI, Rutherford Category, and infragenicular arterial patency was
evaluated.
Results: The median TBI for Rutherford Category 4, 5, and 6 symptoms was
0.320.25 (SD), 0.240.29 (SD), and 0.300.20 (SD), respectively. The median TBI
for 0, 1, 2, and 3-vessel runoff was 0.250.36 (SD), 0.260.21 (SD), 0.290.20
(SD), and 0.430.29 (SD), respectively. There was no statistically signiﬁcant
difference between TBI and Rutherford category (p¼0.42) or number of patent runoff
vessels below the knee (p¼0.80).Conclusions: In a small population of patients, TBI had a non-signiﬁcant correlation
with infragenicular runoff. TBI did not correlate with Rutherford classiﬁcation.
Patients with a high index of clinical suspicion for CLI should undergo further
angiographic evaluation when revascularization may improve outcomes.
TCT-536
Pooled Analysis of the CONFIRM Registries: Outcomes in Elderly Patients
Treated with Orbital Atherectomy for Peripheral Arterial Disease
Michael Lee1
1UCLA Medical Center, Los Angeles, CA
Background: The elderly represent a growing population of patients in the
community. There is a paucity of data about the outcomes of elderly patients with
peripheral arterial disease who undergo orbital atherectomy.
Methods: Our analysis of the CONFIRM I-III registries includes 2995 real-world
patients (4557 lesions) with 1753 patients <75 years of age (2637 lesions) and 1753
patients 75 years of age (1920 lesions) treated with orbital atherectomy. The primary
endpoint was the composite of dissection, perforation, slow ﬂow, vessel closure,
spasm, embolism, and thrombus formation.
Results: Patients 75 years of age had a high proportion of females (47.5% vs.
35.3%, p<0.001), more patients with critical limb ischemia, longer mean lesion length
(75.0  74.1 vs. 69.9  68.9 mm, p¼0.01), and more treatment location below the
knee 38.4% vs. 34.1%, p<0.001). Patients <75 years of age and 75 years of age had
similar rates of the primary end point (22.0% vs. 21.3%, p¼0.81), dissection (11.4%
vs. 10.5%, p¼0.72), vessel closure (1.7% vs. 1.1%, p¼0.13), spasm (6.3% vs. 6.4%,
p¼0.96), and embolism (2.5% vs. 1.6%, p¼0.31). Patients 75 years of age had less
incidence of thrombus formation (0.9% vs. 1.6%, p¼0.03) but higher perforation rate
(1.2% vs. 0.4%, p¼0.007) and a trend towards a higher rate of slow ﬂow (5.3% vs.
4.0%, p¼0.08).
Conclusions: Plaque modiﬁcation with orbital atherectomy provided similar clinical
outcomes in the patients <75 years of age and 75 years of age despite the elderly
having unfavorable baseline clinical and lesion characteristics including more patients
with critical limb ischemia, longer lesions, and treatment below the knee. The higher
rates of perforation and trend towards increased slow ﬂow may be explained by more
extensive disease and smaller vessels.B162 JACC Vol 62/18/Suppl B j October 27–NTCT-537
Long-term Outcomes of Self-Expanding Nitinol Stent Implantation for Chronic
Total Occlusion of the Superﬁcial Femoral and Proximal Popliteal Artery
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Background: Although recent guideline show expanded indication of endovascular
therapy (EVT) for superﬁcial femoral and proximal popliteal artery (SFPA) lesion,
only secondary patency rate after self-expanding nitinol stent implantation is
comparable for vein-graft bypass. Long-term outcomes are necessary for stent
implantation to be considered as ﬁrst-line therapy. This study investigated the long-
term patency rates and predictors of restenosis after self-expanding nitinol stent
implantation for chronic total occlusion (CTO) in SFPA lesions.
Methods: From January 2004 to December 2011, 2742 patients with peripheral artery
disease of SFPA lesion 3471 limbs underwent EVT with a self-expanding nitinol stent
at 13 institutions in Japan. Of the cohort, 1036 patients, 1169 limbs, had stents
implanted for CTOs in the SFPA and were followed as long as 8 years (mean
899607 days). We retrospectively investigated baseline characteristics, patency
rates, clinical outcomes and predictors of loss of primary patency.
Results: Mean age was 739 years and 28% were female patients. Fifty-nine percent
of the patients had diabetes mellitus and 27% were patients with critical limb
ischemia. Occluded length was 18485 mm, 74% was TASC II type C, D lesion.
Mean total stent length was 20389 mm and mean stent diameter was 6.70.8 mm,
mean ﬁnal balloon diameter was 5.20.8 mm. Fifty-two percent administrated cil-
ostazole. Incidence of stent fracture was 6%. Primary, assisted primary, secondary
patency rates were 42%, 63%, 76%, respectively. Mortality rate was 14%, 2.5% went
to surgical bypass, 2.7% had major amputation. In the multivariate analysis, stent
fracture (OR 2.52; p¼0.0016), female gender (OR 1.73; p¼0.0005), use of distal
puncture technique (OR 1.50; p¼0.0096), diabetes mellitus (OR 1.43; p¼0.0148),
ﬁnal balloon diameter (OR 0.23; p¼0.0075), administration of cilostazol (OR 0.65;
p¼0.0052) and use of IVUS (OR 0.71; p¼0.0342) were factors strongly associated
with loss of primary patency.
Conclusions: Although primary patency was low, secondary patency rate was
acceptable.
TCT-538
Catheter directed thrombolysis in deep venous thrombosis with or without
pulmonary thromboembolism
Maddury Jyotsna1, Abhisheka K. Tripathi2
1Nizam's institute of medical sciences, Hydrabad, IN, 2Nizam's institute of medical
sciences, Hyderabad, Andhra Pradesh
Background: As deep venous thrombosis (DVT) treatment with anticoagulation does
not resolve the thrombus formed in the vein, we wanted to study the result of catheter
directed thrombolysis (CDT) in patients with acute DVT with or without pulmonary
thromboembolism (PTE).
Methods: We retrospectively analysed the data of patients who presented with acute
(< 10 days) or sub-acute (< 21 days) or acute on chronic DVT with or without PTE
and were given CDT through Multi-Side port Catheter Infusion Sets Dual Check
Valve 5F perfusion catheter (65 or 100cm from Cook's company), in our unit in the
year 2012. CDT was done with streptokinase, 250,000 U as a loading dose over 30
minutes, followed by 100,000 U/h over 24 hours. CT pulmonary angio and venous
colour Doppler was done before and 24 hrs after CDT was done. Success of CDT was
deﬁned as complete or partial depending on complete or reduction of thrombus burden
in pulmonary arteries &/or deep veins.
Results: A total of 22 patients presented with Acute DVT in our unit [15 (68.2%)
males and 7 (31.8%) females with mean age of 42.6  13.6 yrs ] in 2012. Out of
them 11 (50%) had PTE, 6 massive and 5 sub massive and 9 had PAH . 14(63.6%)
had Acute, 4 (18.2%) had sub-acute & 4 (18.2%) had acute on chronic DVT. 8
patients had predisposing factors (immobilization 4, adrenal adenoma 1, hyper-
homocysteinemia 1, haemodialysis related 1, venous stenosis 1). Simultaneously
IVC ﬁlter implantation in 12 (54.5%) and venous stenting in one patient was done.
After 24 hrs of CDT , 11 (50%) DVT patients had complete resolution of thrombus
and 11 (50%) had partial resolution (even in this group proximal thrombus in iliac
veins was disappeared in all except one). Out of 11 patients who had PTE, 8 had
complete resolution of thrombus and 3 had partial. Pulmonary artery pressure
normalized in 7 (7/9- 77.8%). In 3 patients IVC ﬁlters were retrieved. One patient had
puncture site hematoma which was managed conservatively. No fatal complication
was noted.ovember 1, 2013 j TCT Abstracts/POSTER/Endovascular Intervention
